Readings Newsletter
Become a Readings Member to make your shopping experience even easier.
Sign in or sign up for free!
You’re not far away from qualifying for FREE standard shipping within Australia
You’ve qualified for FREE standard shipping within Australia
The cart is loading…
This story highlights the positive impact that pre-dialysis information can have on optimizing the management of end-stage renal disease. This can take the form of "patient choice" of dialysis method. At the same time, we note the lack of visibility of peritoneal dialysis. This study follows on from a number of achievements I have made over the course of my professional life, in various hospitals and associations. In my "home countries" of Guinea and Cote d'Ivoire, hemodialysis is the mainstay of treatment. The abundance of treatment available in France opens the way to "choice". So we need to provide information in order to adapt the treatment, and thus have a "positive" influence on the patient's quality of life. Making this mechanism "agile" must remain a permanent challenge for every Nephrology Center. And also to "fight" to improve it, by keeping pace with developments in therapeutic approaches to end-stage chronic renal failure.
$9.00 standard shipping within Australia
FREE standard shipping within Australia for orders over $100.00
Express & International shipping calculated at checkout
This story highlights the positive impact that pre-dialysis information can have on optimizing the management of end-stage renal disease. This can take the form of "patient choice" of dialysis method. At the same time, we note the lack of visibility of peritoneal dialysis. This study follows on from a number of achievements I have made over the course of my professional life, in various hospitals and associations. In my "home countries" of Guinea and Cote d'Ivoire, hemodialysis is the mainstay of treatment. The abundance of treatment available in France opens the way to "choice". So we need to provide information in order to adapt the treatment, and thus have a "positive" influence on the patient's quality of life. Making this mechanism "agile" must remain a permanent challenge for every Nephrology Center. And also to "fight" to improve it, by keeping pace with developments in therapeutic approaches to end-stage chronic renal failure.